Enhancing in vivo effect of propranolol on human lymphocyte function is not due to stereospecific beta-adrenergic blockade

Agents Actions. 1993 Mar;38(3-4):281-5. doi: 10.1007/BF01976221.

Abstract

Immunoenhancing in vivo effects of beta-adrenergic blockers have been previously ascribed to a reduced beta-receptor-mediated immunosuppression. In the present study using a whole blood stimulation assay, the effects of a five-day treatment with the purified (R)- or (S)-isomer of propranolol (3 x 40 mg/day) on the polyclonal in vitro responsiveness of peripheral blood lymphocytes (PBL) of normothyroid and hyperthyroid persons were assessed. It is shown that both isomers likewise exhibit a significant enhancing effect on the proliferative response of PBL to T and B cell mitogens, which strongly argues for nonspecific effects of propranolol to be responsible rather than a specific beta-adrenergic receptor blockade.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Follow-Up Studies
  • Humans
  • Hyperthyroidism / immunology
  • Leukocyte Count / drug effects
  • Lymphocyte Activation / drug effects
  • Middle Aged
  • Propranolol / administration & dosage
  • Propranolol / pharmacology*
  • Receptors, Adrenergic, beta / drug effects*
  • Receptors, Adrenergic, beta / metabolism
  • Stereoisomerism
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology

Substances

  • Receptors, Adrenergic, beta
  • Propranolol